Long non-coding RNA Neat1 and paraspeckle components are translational regulators in hypoxia

  1. Anne-Claire Godet
  2. Emilie Roussel
  3. Florian David
  4. Fransky Hantelys
  5. Florent Morfoisse
  6. Joffrey Alves
  7. Françoise Pujol
  8. Isabelle Ader
  9. Edouard Bertrand
  10. Odile Burlet-Schiltz
  11. Carine Froment
  12. Anthony K Henras
  13. Patrice Vitali
  14. Eric Lacazette
  15. Florence Tatin
  16. Barbara Garmy-Susini
  17. Anne-Catherine Prats  Is a corresponding author
  1. UMR 1297-I2MC, Inserm, Université de Toulouse, France
  2. UMR 1301-RESTORE, Inserm, CNRS 5070, Etablissement Français du Sang-Occitanie (EFS), National Veterinary School of Toulouse (ENVT), Université de Toulouse, France
  3. UMR5535 CNRS-IGMM, Université de Montpellier, France
  4. Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, France
  5. Molecular, Cellular and Developmental Biology Unit (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, France
10 figures, 1 video, 2 tables and 9 additional files

Figures

Figure 1 with 3 supplements
FGF1 IRES activation during hypoxia correlates with Neat1 induction and paraspeckle formation.

(A) Schema depicting the Lucky Luke bicistronic construct and HL-1 cells transduced by a lentivector carrying the transgene. The LucF/LucR ratio indicates the IRES activity. (B) Activity of the …

Figure 1—figure supplement 1
Bicistronic vector LucR and LucF expression and endogenous FGF1 protein expression in hypoxic HL-1 cells.

Renilla (A) and firefly (B) luciferase activities were measured in HL-1 cardiomyocytes transduced by the bicistronic vector with the FGF1 IRES, after 4 hr, 8 hr, or 24 hr of hypoxia or normoxia. The …

Figure 1—figure supplement 2
Detection of Neat1 and Neat1_2 in hypoxic HL-1 by FISH.

FISH experiment with representative images of Neat1 (both isoforms)(left panels) or Neat1_2 isoform (right panels) in normoxia and hypoxia at 4 hr, 8 hr, 24 hr in HL-1 cardiomyocytes. DAPI, Neat1

Figure 1—figure supplement 3
FGF1 IRES is activated by hypoxia in correlation with Neat1 induction in 67NR cells and inactivated after Neat1 knock-down.

(A–B) 67NR cells (mouse breast cancer) were subjected to normoxia (0 hr) or to hypoxia (1% 02) during 4 hr, 8 hr and 24 hr. Neat1 (A) or Neat1_2 (B) expression was analyzed by RT qPCR (Primer …

Figure 2 with 6 supplements
LncRNA Neat1 knock-down drastically affects the FGF1 IRES activity and endogenous FGF1 expression.

(A) SmiFISH imaging of Neat1 knock-down by a pool of LNA gapmers targeting both isoforms (Sequences in Supplementary file 2C). Cells were treated during 48 hr with the gapmers. Scale bar = 10 µm. (B)…

Figure 2—figure supplement 1
Knock-down of Neat1 and Neat1_2 in HL-1 cardiomyocytes.

Neat1 knock-down was performed in HL-1 cells using pooled LNA gapmers against Neat1 (48 hr)(A) or Neat1_2 (72 hr)(B). Neat1 and Neat1_2 RNA expression was measured by droplet digital PCR and …

Figure 2—figure supplement 2
Effect of Neat1 knock-down on endogenous FGF1 protein expression.

Endogenous mouse FGF1 was detected using anti-FGF1 antibody in hypoxic HL-1 cells treated either by control gapmer (ctrl) or Neat1_2 gapmer by capillary Simple Western. The source data of the …

Figure 2—figure supplement 3
Effect of Neat 1_2 knock-down on FGF1 IRES activity.

Neat1-2 knock-down was performed in HL-1 cells transduced by the bicistronic lentivector with the FGF1 IRES during normoxia or hypoxia (1% O2). Luciferase activities as well as the LucF/LucR ratios …

Figure 2—figure supplement 4
Effect of Neat1_2 knock-down on eIF2α phosphorylation.

Expression and phosphorylation of eIF2α in HL-1 cells either untreated (NT) or treated by control gapmer (ctrl) or Neat1_2 gapmer were measured using anti-eIF2α (A) and anti-phospho-eIF2α antibodies …

Figure 2—figure supplement 5
FGF1 half-life after Neat1_2 gapmer treatment.

(A–E) FGF1 half-life was determined in HL-1 cells treated with control gapmer, Neat1_2 gapmer or untreated. The half-life determination was performed by blocking protein synthesis with cycloheximide …

Figure 2—figure supplement 6
p21 half-life after Neat1_2 gapmer treatment.

(A–E) p21 half-life half-life was determined as a control in HL-1 cells treated with control gapmer, Neat1_2 gapmer or untreated, in the experiment shown in Figure 2—figure supplement 5. p21 protein …

IRES-containing mRNA is colocalized with Neat1 in hypoxic HL-1 cells.

Cells were transduced with lentivectors carrying bicistronic Lucky Luke constructs with the FGF1 IRES or a hairpin (control), subjected or not to 4 hr hypoxia. SmiFISH experiments were performed. (A)…

Figure 4 with 4 supplements
Paraspeckle proteins p54nrb and PSCP1, but not SFPQ, are ITAFs of the FGF1 IRES.

(A) Schema of paraspeckle and DBHS proteins. (B–D) FGF1 IRES activity upon knock-down of SFPQ (B), P54nrb (C) or PSPC1 (D) in HL-1 cell (Figure 4—figure supplement 1—source data 1) transduced with …

Figure 4—figure supplement 1
Knock-down of p54nrb, PCPC1 and SFPQ in HL-1 cardiomyocytes.

(A–B) Capillary Simple Western detection (as described in Figure 2) of p54nrb (A) and PSPC1 (B) proteins using anti-p54nrb and anti-PSPC1 antibodies, respectively, following p54nrb and PSPC1 …

Figure 4—figure supplement 2
FGF1 protein expression in response to p54nrb or PSPC1 knock-down.

Endogenous FGF1 protein was detected by Capillary Simple Western in conditions of P54nrb or PSPC1 knock-down mentioned in Figure 4—figure supplement 1. The raw data presented correspond to the …

Figure 4—figure supplement 3
FGF1 half-life in response to p54nrb or PSPC1 knock-down.

FGF1 half-life was determined on HL-1 cells treated with p54nrb siRNA, PSPC1 siRNA or control siRNA, by blocking protein synthesis with cycloheximide at 10 μg/mL, with time-course points at 0 hr, 30 …

Figure 4—figure supplement 4
p21 half-life in response to p54nrb or PSPC1 knock-down.

p21 half-life was determined on HL-1 cells treated with p54nrb siRNA, PSPC1 siRNA or control siRNA in the same experiment as in that presented in Figure 4—figure supplement 3. p21 protein stability …

Figure 5 with 2 supplements
P54nrb interactome in normoxic and hypoxic cardiomyocytes.

(A) Experimental workflow: p54nrb-HA transduced HL-1 cells were subjected to normoxia or hypoxia, then nucleus and cytoplasm fractionation was performed and extracts were immunoprecipitated using …

Figure 5—figure supplement 1
Western blot of fractionation experiment of HL-1 cells and label-free quantitative analysis of HA-P54nrb-bound proteins identified by mass spectrometry in different conditions.

(A-B) Raw data of the Western blots using nuclear or cytoplasmic extracts of HL-1 cells in normoxia and hypoxia, presented in Figure 5B. (A) Western blot successively blotted with anti-GAPDH, …

Figure 5—figure supplement 2
p54nrb is co-immunoprecipitated by anti-nucleolin antibody.

Immunoprecipitation was performed from HL-1 cell nuclear extracts, using either IgG (negative control), or antibody against p54nrb, or antibody against nucleolin. Capillary Simple Western (Jess) was …

Figure 6 with 1 supplement
p54nrb-interacting proteins, nucleolin and RPS2, control the FGF1 IRES activity.

(A–C) Quantification of RPS2 (A), hnRNPM (B) and nucleolin (C) RNA expression in HL-1 cells transfected with siRNAs against Rps2, hnRNPM or nucleolin mRNA, respectively. RNA expression was measured …

Figure 6—figure supplement 1
Endogenous FGF1 protein expression is down-regulated following nucleolin knock-down.

Knock-down of nucleolin was achieved in HL-1 cells using siRNA against nucleolin mRNA. Capillary Simple Western were performed using anti-nucleolin (A) of anti-FGF1 antibody (B). The source data of …

Neat1 is the key activator of (lymph)angiogenic and cardioprotective factor mRNA IRESs.

(A–C) HL-1 subjected to normoxia or 1% O2 hypoxia were transduced by Lucky Luke bicistronic lentivectors with FGF1, FGF2, VEGFAa, VEGFAb, VEGFC, VEGFD, IGF1R, MYC, or EMCV IRES, then the knock-down …

Figure 8 with 2 supplements
Neat1_2 knock-down down-regulates translation of most IRES-containing RNAs as well as mRNAs coding ITAFs.

HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1_2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. The polysome profile is presented in Figure …

Figure 8—figure supplement 1
Polysome profiles of HL-1 cardiomyocytes treated by gapmer Neat1 or Neat1_2, compared to gapmer control.

In order to isolate translated mRNAs, polysomes from transfected HL-1 cardiomyocytes were purified on a sucrose gradient, as described in Star Methods. Polysomal profiles of HL-1 cardiomyocytes …

Figure 8—figure supplement 2
Effect of Neat1 and Neat1_2 knock-down on translation of mRNAs coding angiogenic and cardioprotective factors.

HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1-2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. Polysome profile is presented in Figure …

Model of IRESome formation in the paraspeckle.

According to the present data, we propose that the paraspeckle may be a recruitment platform for IRES-containing mRNAs in hypoxic cardiomyocytes. Neat1 and proteins present in the paraspeckle (among …

Author response image 1
FGF1 IRES activity after DDX17 knock-down.

Videos

Video 1
Beating HL-1 cardiomyocytes (Enlargement 40X).

Mouse atrial HL-1 cardiomyocytes exhibit a beating phenotype when cultured in Claycomb medium at high density (Claycomb et al., 1998). This phenotype was required to obtain all the data described in …

Tables

Table 1
The p54 interactome includes 22 among 40 proteins described as paraspeckle components.

The paraspeckle components listed in the reports by Naganuma et al., 2012 and by Yamamoto et al., 2021 is presented here with their ITAF function and their presence in the p54nrb interactome. Their …

NameAlternative nameClassITAFPresence in p54nrb MS-IP
ASXL1MDS/BOPSINoNo
CELF6n/dNoNo
CIRBPIIIBNoYes
CPSF6IIIANoYes
CPSF7IINoYes
DAZAP1IBNoYes
DLX3n/dNoNo
EWSR1NoYes
FAM113AIINoNo
FAM98AIINoYes
FIGNIINoNo
FUSIBYesYes
FUSPI1SRSF10IINoYes
hnRNPA1IIYesYes
hnRNPA1L2n/dNoNo
hnRNPFn/dNoYes
hnRNPH1n/dNoYes
hnRNPH3IBNoNo
hnRNPKIAYesYes
hnRNPMn/dYesYes
hnRNPRIIYesNo
hnRNPUL1IINoYes
MEX3Cn/dNoNo
NUDT21IIIANoYes
p54nrbNONOIAYesYes
PSPC1IIIBNoYes
RBM12IINoNo
RBM14IANoNo
RBM3IIIBNoYes
RBM4BIIIBNoNo
RBM7IIIBNoNo
RBMXIIIBNoYes
RUNX3IIIBNoNo
SFPQPSFIAYesYes
SS18L1n/dNoNo
SWI/SNFIBNoNo
TAF15NoNo
TDP-43IINoNo
UBAP2LIIIANoYes
ZNF335TARDBPIIIBNoYes
Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
AntibodyAnti-P54nrb
(rabbit polyclonal)
SantacruzSc-67016Dilution 1:200
(capillary Western)
Dilution 1:400
(classical Western)
AntibodyAnti-PSPC1
(rabbit polyclonal)
bethyl laboratoryA303-205ADilution 1:100
(capillary Western)
Dilution 1:1000
(classical Western)
AntibodyAnti-SFPQ
(mouse monoclonal)
AbcamAb11825Dilution 1:100
AntibodyAnti-FGF1
(rabbit polyclonal)
AbcamAb207321Dilution 1:25
AntibodyAnti-nucleolin
(rabbit polyclonal)
Novus biologicalNB600-241Dilution 1:50
AntibodyAnti-Histone H3
(rabbit polyclonal)
Cell Signaling4499Dilution
1 : 10000
AntibodyAnti-GAPDH
(mouse monoclonal)
SantaCruzSc-32233Dilution 1:1000
AntibodyMouse
total IgG
(mouse polyclonal)
SigmaI53812 mg/mL
AntibodyAnti-eIF2α
(rabbit polyclonal)
Cell Signaling Technology9721Dilution 1:50
AntibodyAnti-phospho-eIF2α
(mouse monoclonal)
Cell Signaling Technology2103Dilution 1:50
AntibodyAnti-p21
(mouse monoclonal)
SantacruzSc-6246Dilution 1:50
AntibodyAnti-HA
(mouse monoclonal)
SigmaH9558/H36632.4 mg/mL
(72 μg)
AntibodyAnti-rabbit-peroxidase conjugate
(donkey polyclonal)
Jackson ImmunoResearch711-035-152Dilution 1:10000
AntibodyAnti-mouse-peroxidase conjugate
(rabbit polyclonal)
Jackson ImmunoResearch715-035-150Dilution 1:10000
AntibodyRabbit detection moduleProtein SimpleDM-00110 μl
AntibodyMouse detection moduleProtein SimpleDM-00210 μl
Strain, strain background (Escherichia coli)Top10InVitrogenC404003
Strain, strain background (Escherichia coli)StratacloneAgilent technologies200185
Chemical compound, drugTRI-ReagentMRC IncTR118
Chemical compound, drugIsopropanolSigma-Aldrich33539
Chemical compound, drugEthanolSigma-Aldrich32221
Chemical compound, drugDigitoninSigma-AldrichD141
Chemical compound, drugNP40 (IGEPAL 630)Sigma-AldrichI8896
Chemical compound, drugEDTAEuromedexEU0084-A
Chemical compound, drugProteinase inhibitor cocktailSigma-AldrichP2714
Chemical compound, drugRNAse inhibitorAppliedBiosystemN8080119
Chemical compound, drugFormamideInvitrogen15515026
Chemical compound, drugParaformaldehyde 16%Electron Microscopy Science
Chemical compound, drugSSC saline-sodium citrate bufferEuromedexEU0300-C
Chemical compound, drugRIPABioBasicRB4476
Peptide, recombinant proteinHA peptidesSigma-AldrichI2149
Commercial assay or kitPremix Ex Taq IITakaraRR820B
Commercial assay or kitEZ view red protein G beadsSigmaE3403
Commercial assay or kitDG32 cartridgeBio-Rad#1864108
Commercial assay or kitQX200 ddPCR EvaGreen SupermixBio-Rad1864034
Commercial assay or kitHigh capacity cDNA Reverse transcription kitThermofisher4368814
Commercial assay or kitNucleoBond Xtra Maxi kitsMacherey-Nagel740414.10
Commercial assay or kitEZ-10 Spin Column Plasmid DNA Miniprep KitBioBasicBS413
Commercial assay or kitStrataClone Blunt PCR Cloning KitAgilent240207
Commercial assay or kitDual-Luciferase Reporter Assay systemPromegaE1980
Commercial assay or kitJess or Wes Separation ModuleProteinSimpleSM-SW004
Commercial assay or kitFluorescent 5 x Master Mix 1ProteinSimplePS-FL01-8
Cell line (Homo-sapiens)293 FTInvitrogenR700-07
Cell line (Homo-sapiens)HT1080ATCCCCL-121
Cell line (Mus musculus)HL-1(Claycomb et al., 1998) / Sigma-AldrichSCC065Beating cardiomyocytes (Video 1)
Sequence-based reagentNEAT1This paperPCR primersSupplementary file 2
Sequence-based reagentFGF1This paperPCR primersSupplementary file 2
Sequence-based reagentNEAT1_2This paperPCR primersSupplementary file 2
Sequence-based reagentHPRTThis paperPCR primersSupplementary file 2
Sequence-based reagentRPL11This paperPCR primersSupplementary file 2
Sequence-based reagent18 SHantelys et al., 2019PCR primersSupplementary file 2
Sequence-based reagentSFPQThis paperPCR primersSupplementary file 2
Sequence-based reagentP54nrbThis paperPCR primersSupplementary file 2
Sequence-based reagentPSPC1This paperPCR primersSupplementary file 2
Sequence-based reagentNUCLEOLINThis paperPCR primersSupplementary file 2
Sequence-based reagentRPS2This paperPCR primersSupplementary file 2
Sequence-based reagentHNRNPMHantelys et al., 2019PCR primersSupplementary file 2
Sequence-based reagentFluidigm deltagene probesThis paperPCR primersSupplementary file 2
Sequence-based reagentNeat1 and Neat1_2 FISH probesThis paperHybridization probesSupplementary file 2
Sequence-based reagentSmiFISH secondary probes (FLAP X-Cy3 and FLAP-Y-Cy5)This paperHybridization probesSupplementary file 2
Sequence-based reagentSmiFISH Neat1 primary probesThis paperHybridization probesSupplementary file 2
Sequence-based reagentSmiFISH bicistronic Lucky Luke mRNA primary probesThis paperHybridization probesSupplementary file 2
Sequence-based reagentHA-p54nrbThis paperCloning primersSupplementary file 2
Sequence-based reagentmiR-Neat1-G2This paperCloning primersSupplementary file 2
Sequence-based reagentmiR-Neat1_2-G6This paperCloning primersSupplementary file 2
Sequence-based reagentmiR-Neat1_2-G7This paperCloning primersSupplementary file 2
Sequence-based reagentP54nrb mouseDharmacon
E-048587-01-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagentPSPC1 mouseDharmacon
E-049216-00-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagentSFPQ mouseDharmacon
E-044760-00-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagentNucleolin mouseDharmacon
E-059054-00-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagentRps2 mouseDharmacon
E-049205-00-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagenthnRNPM mouseDharmacon
E-044465-00-0005
siRNA smartpoolSupplementary file 2
Sequence-based reagentsiRNA non-targeting controlDharmacon
D-001910-10-20
siRNASupplementary file 2
Sequence-based reagentNEAT1 ALG00218175LNA gapmerSupplementary file 2
Sequence-based reagentNEAT1 BLG00218176LNA gapmerSupplementary file 2
Sequence-based reagentNEAT1 CLG00218177LNA gapmerSupplementary file 2
Sequence-based reagentNEAT1 DLG00218178LNA gapmerSupplementary file 2
Sequence-based reagentNEAT1_2LG00234548LNA gapmerSupplementary file 2
Sequence-based reagentNEGATIVE CONTROLLG00000002LNA gapmerSupplementary file 2
Recombinant DNA reagentpTRIP-CRHL+Sequence available on Dryad, (2)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRF1AL+Sequence available on Dryad, (17; 26)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRFL+Sequence available on Dryad, (25)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRVAaL+Sequence available on Dryad, (16)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRVAbL+Sequence available on Dryad, (16)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRhVCL+Sequence available on Dryad, (2)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRhVDL+Sequence available on Dryad, (13)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRMP2L+Sequence available on Dryad, (42)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CREL+Sequence available on Dryad, (25)SIN lentivector plasmiddoi:10.5061/dryad.nvx0k6dq7
Recombinant DNA reagentpTRIP-CRIGL+This paperSIN lentivector plasmiddoi:10.5061/dryad.m0cfxpp75
Recombinant DNA reagentpCMV-dR8.91AddgenePlasmid for lentivector production
Recombinant DNA reagentpCMV-VSV-GAddgenePlasmid for lentivector production
Recombinant DNA reagentpTRIP-Neat1-miR-G2This paperSIN lentivector plasmiddoi:10.5061/dryad.m0cfxpp75
Recombinant DNA reagentpTRIP-Neat1_2-miR-G6This paperSIN lentivector plasmiddoi:10.5061/dryad.m0cfxpp75
Recombinant DNA reagentpTRIP-Neat1_2-miR-G7This paperSIN lentivector plasmiddoi:10.5061/dryad.m0cfxpp75
Recombinant DNA reagentpTRIP-HA2-P54nrbThis paperSIN lentivector plasmiddoi:10.5061/dryad.m0cfxpp75
Software, algorithmPrism 6GraphpadSoftware to perform statisticshttps://www.graphpad.com/scientific-software/prism/
Software, algorithmExcel 2007Microsoft officeSoftware to perfom graphs and tables
Software, algorithmFIJIFIJISoftware for image analysishttps://fiji.sc/
Software, algorithmImageJImageJ/NIHSoftware for image analysishttps://imagej.nih.gov/ij/download.html
Software, algorithmZen black/Blue editionZeissMicroscope softwarehttps://www.zeiss.fr/microscopie/produits/microscope-software/zen-lite.html
Software, algorithmQuantStudioAppliedBiosystemsQuantification softwarehttps://www.thermofisher.com/fr/fr/home/global/forms/life-science/quantstudio-3-5-software.html
Software, algorithmQuantaSoft 1.7.4Bio-RadWestern blot quantification softwarehttps://www.bio-rad.com/fr-fr/sku/1864011-quantasoft-software-regulatory-edition?ID=1864011
Software, algorithmMicrowin 2000BertholdMicroplaque testing softwarehttps://fr.freedownloadmanager.org/Windows-PC/MikroWin-2000.html
Software, algorithmLSM780 Zeiss confocal microscopeZeissMicroscope softwareN/A
Software, algorithmCompass for SWProtein SimpleCapillary Western softwareN/A

Additional files

Supplementary file 1

IRES activities in normoxic and hypoxic HL-1 cells after Neat1 knock-down.

HL-1 cells were transduced with Lucky Luke bicistronic lentivector containing the IRES of FGF1 mRNA. Cells were submitted to normoxia or hypoxia 1% O2 during 4 hr, 8 hr or 24 hr. Renilla and firefly luciferase activities were measured (page 1) and the IRES activities evaluated with the ratio LucF/LucR (page 2). Mann-Whitney test was performed with n=12. **P<0.01. For each hypoxia condition the mean of the LucF/LucR ratio has been calculated with 12 cell culture biological replicates, normalized to normoxia Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3, 4 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (36 technical replicates in total).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp1-v2.docx
Supplementary file 2

Sequences of FISH and smiFISH probes, PCR primers, gapmers, siRNAs and Fluidigm probes.

A/ FISH and smiFISH probes. B/ qPCR primers and cloning primers. C/ LNA gapmers used in Neat1 knock-down assays. D/ SiRNA SMARTpools (Dharmacon) used for IRES activity studies. E/ Fluidigm deltagene primers. The corresponding genes are indicated in the left column.

https://cdn.elifesciences.org/articles/69162/elife-69162-supp2-v2.docx
Supplementary file 3

IRES activities in normoxic and hypoxic HL-1 cells after Neat1 knock-down.

HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with a pool of gapmers Neat1, or control during normoxia or hypoxia 1% O2. For the lentivector with FGF1 IRES, cells were also treated with the gapmer Neat1_2 (N1_2, page 2). Renilla and firefly luciferase activities were measured (upper panel) and the IRES activities evaluated with the ratio LucF/LucR (lower panel). Mann-Whitney test was performed with n=9. *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp3-v2.docx
Supplementary file 4

FGF1 IRES activity in normoxic and hypoxic HL-1 cells after Sfpq, Rps2, Hnrnpm knock-down.

HL-1 cells were transduced with a Lucky Luke bicistronic lentivector containing the IRES of FGF1. Cells were then treated with siSfpq (A), siRps2 (B), sihnRNPM (C), siNucleolin (siNcl, D) or siControl (siCtrl) smartpools during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured and the IRES activities evaluated with the ratio LucF/LucR. Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each siRNA the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp4-v2.docx
Supplementary file 5

IRES activities in normoxic and hypoxic HL-1 cells after p54nrb knock-down.

HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with siP54nrb or siControl (siCtrl) smartpool during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured (upper panel, or page 1 for FGF1 IRES) and the IRES activities evaluated with the ratio LucF/LucR (lower panel, or page 2 for FGF1 IRES). Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp5-v2.docx
Supplementary file 6

IRES activities in normoxic and hypoxic HL-1 cells after Pspc1 knock-down.

HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with siPSPC1 or siControl (siCtrl) smartpool during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured (upper panel, or page 1 for FGF1 IRES) and the IRES activities evaluated with the ratio LucF/LucR (lower panel, or page 2 for FGF1 IRES). Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp6-v2.docx
Supplementary file 7

Label-free quantitative analysis of HA-P54nrb-bound proteins identified by mass spectrometry in different conditions.

p54nrb-HA transduced HL-1 cells were subjected to normoxia or hypoxia, then nucleus and cytoplasm fractionation was performed and extracts were immunoprecipitated using anti-HA antibody. Enriched interacting proteins were identified by using a label-free quantitative mass spectrometry approach. The dataset list of proteins identified by MS/MS is presented in alphabetical order. An unpaired bilateral student t-test with equal variance was used. Enrichment significance thresholds correspond to an absolute log2-transformed fold-change (FC) greater than 1 and a -log10-transformed (p-value) greater than 1.3.

https://cdn.elifesciences.org/articles/69162/elife-69162-supp7-v2.xlsx
Supplementary file 8

Change of mRNA recruitment into polysomes following Neat1 or Neat1_2 knock-down.

HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1_2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. RNAs were purified from cytoplasmic extracts and from pooled polysomal fractions and analyzed on a Fluidigm deltagene PCR array from two biologicals replicates (cell culture dishs and cDNAs), each of them measured in three technical replicates (PCR reactions). mRNA levels in polysomes (polysomal RNA/ total RNA) were analyzed for each gene. Relative quantification (RQ) of mRNA level was calculated using the 2–ΔΔCT method with normalization to Gapdh mRNA and to HL-1 tranfected by gapmer control, and is shown as fold change of expression. RQ1 and RQ2 correspond to two independent experiments. To measure the fold change of repression, the mean is expressed as –1/RQ for the values <1 (yellow column).

https://cdn.elifesciences.org/articles/69162/elife-69162-supp8-v2.docx
Transparent reporting form
https://cdn.elifesciences.org/articles/69162/elife-69162-transrepform1-v2.docx

Download links